IL-17 levels are elevated in the serum and cerebrospinal fluid (CSF) of MS patients and are correlated with MS disease severity, consequently suggesting a pathogenic role of Th17 cells in MS (55, 56). Here, IL17A is linked to myeloid sarcoma.